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Methods
Inferring tumor progression from genomic
heterogeneity
Nicholas Navin,1,2 Alexander Krasnitz,1 Linda Rodgers,1 Kerry Cook,1 Jennifer Meth,1
Jude Kendall,1 Michael Riggs,1 Yvonne Eberling,1 Jennifer Troge,1 Vladimir Grubor,1
Dan Levy,1 Pa¨r Lundin,3 Susanne Ma˚ne´r,3 Anders Zetterberg,3 James Hicks,1
and Michael Wigler1,4
1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA; 2Department of Molecular Genetics & Microbiology,
Stony Brook University, Stony Brook, New York 11794, USA; 3Karolinska Institutet, Department of Oncology–Pathology,
171 76 Stockholm, Sweden
Cancer progression in humans is difficult to infer because we do not routinely sample patients at multiple stages of their
disease. However, heterogeneous breast tumors provide a unique opportunity to study human tumor progression because
they still contain evidence of early and intermediate subpopulations in the form of the phylogenetic relationships. We have
developed a method we call Sector-Ploidy-Profiling (SPP) to study the clonal composition of breast tumors. SPP involves
macro-dissecting tumors, flow-sorting genomic subpopulations by DNA content, and profiling genomes using compar-
ative genomic hybridization (CGH). Breast carcinomas display two classes of genomic structural variation: (1) mono-
genomic and (2) polygenomic. Monogenomic tumors appear to contain a single major clonal subpopulation with a highly
stable chromosome structure. Polygenomic tumors contain multiple clonal tumor subpopulations, which may occupy the
same sectors, or separate anatomic locations. In polygenomic tumors, we show that heterogeneity can be ascribed to a few
clonal subpopulations, rather than a series of gradual intermediates. By comparing multiple subpopulations from
different anatomic locations, we have inferred pathways of cancer progression and the organization of tumor growth.
[Supplemental material is available online at http://www.genome.org. The microarray data from this study have been
submitted to the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession no. GSE16672.]
As cancers progress they accumulate genomic changes, including
deletions and amplifications (Hanahan and Weinberg 2000;
Albertson 2006), translocations (Mitelman et al. 2007), point
mutations (Sjo¨blom et al. 2006; Ley et al. 2008; Stratton et al.
2009), and metastable epigenetic events such as changes in DNA
methylation (Widschwendter and Jones 2002; Feinberg andTycko
2004). In many cases, the discovery and classification of these
changes have led to major insights into cancer. Genomic tools
such as expression profiling, array-based copy number analysis,
high-throughput DNA sequencing, andDNAmethylation analysis
have accelerated the accumulation of data about individual can-
cers. The resulting picture is quite complex. For example, the
number of recurrent copy number changes even in specific solid
cancer subtypes is very large (Loo et al. 2004; Hicks et al. 2006;
Adelaide et al. 2007; Haverty et al. 2008), and it is difficult to infer
the sequence of genomic alterations in any given tumor by ana-
lyzing a single sample from the tumor. Here we explore what ad-
ditional information is gained, beyond studyingmutations in large
collections of tumors, by studying mutations in distinct sub-
populations of single tumors.
As a matter of practice, histopathologists observe tumor het-
erogeneity (Komaki et al. 2006) when they examine tissue sections
from many regions of tumors, and they classify each tumor by its
highest observed malignant grade (Ignatiadis and Sotiriou 2008).
Previous molecular studies have also reported heterogeneity in
various forms: transcript expression (Cole et al. 1999; Bachtiary
et al. 2006), protein levels (Allred et al. 2008; Johann et al. 2009),
single nucleotide polymorphisms (Khalique et al. 2007), and
chromosomal rearrangements (Aubele et al. 1999). Heterogeneity
has also been frequently observed in the analysis of karyotypes in
breast tumors from single patients (Teixeira et al. 1995, 1996; Hein
et al. 1997). Several studies have also reported genetic heteroge-
neity in solid breast tumors using fluorescent in situ hybridization
(FISH) experiments on interphase nuclei (Fiegl et al. 1995; Roka
et al. 1998; Farabegoli et al. 2001). These experiments commonly
report that a specific FISH probe measures different copy number
signals in individual cancer cells from the same tumor. However,
studies based on histopathology or just a fewmarkers cannot have
the richness of information that can be obtained by modern ge-
nomic methods. We theorized that copy number profiling of
multiple sectors of a solid tumor would have the potential to
greatly clarify the extent and patterns of tumor progression.
Assuming that themutational complexity of a tumor increases
with time, the history of its progression can be partially inferred by
comparing the distinguishable subpopulations. To separate geno-
mic subpopulations, we initially dissected solid breast tumors and
compared the genome profiles, which revealed genomic heteroge-
neity and encouraged us to further separate tumor subpopulations
by ploidy. Thus, we devised the Sector-Ploidy-Profiling (SPP) ap-
proach. SPP involves macro-dissecting solid tumors into multiple
sectors, isolating and flow-sorting nuclei by total genomic DNA
content, and analyzing the genome structure of tumor sub-
populations by a form of comparative genomic hybridization
(CGH) called representational oligonucleotide microarray analysis
4Corresponding author.
E-mail wigler@cshl.edu; fax (516) 367-8381.
Article published online before print. Article and publication date are at
http://www.genome.org/cgi/doi/10.1101/gr.099622.109. Freely available
online through the Genome Research Open Access option.
68 Genome Research
www.genome.org
20:68–80  2010 by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/10; www.genome.org
 Cold Spring Harbor Laboratory Press on October 5, 2011 - Published by genome.cshlp.orgDownloaded from 
(ROMA) (Lucito et al. 2003). We then used algorithms to compare
the genomes of tumor subpopulations to assess their divergence,
thereby identifying genetic elements that may be involved in tu-
mor progression. To understand the organization of tumor sub-
populations at the single-cell level, we conducted further cytological
studies by interphase FISH.
We applied our methods to 20 primary ductal breast carci-
nomas, which enable us to classify them according to whether
they appear as eithermonogenomic (nine tumors) or polygenomic
(11 tumors). We define ‘‘monogenomic’’ tumors to be those con-
sisting of an apparently homogeneous population of tumor cells
with highly similar genome profiles throughout the tumor mass.
We define ‘‘polygenomic’’ tumors as those containing multiple
tumor subpopulations that can be distinguished and grouped by
similar genome structure. We find that polygenomic tumors may
exhibit two anatomical organizations of their tumor subpopula-
tions: segregated and intermixed. Our results show that the sub-
populations in polygenomic tumors may differ by large genomic
events or focal amplifications and deletions, but that in all cases
the majority of chromosome breakpoints are shared. We con-
structed distance trees that show that tumor subpopulations share
a common genetic lineage, and that each divergent subpopulation
represents a branch in the evolution of a solid tumor.
Results
Copy number analysis of tumors by sector
We hypothesized that some solid tumors contain subpopulations
with major variation in their genome structure, and that these
might be prominent in separate sectors. To test this hypothesis, we
macro-dissected four primary ductal carcinomas (T1–T4) into four
sectors (S1–S4), then isolated DNA and quantified genome-wide
copy number variation using ROMA (Supplemental Fig. S1; Sup-
plemental Table S1). These tumors were randomly selected from
a large collection of frozen ductal carcinomas. Two tumors ana-
lyzed by thismethod (T1, T2) containedminimal variation in their
genomic copy number profiles in all four sectors. Our data in-
dicated that T1 contained 39 chromosomal breakpoints that were
common to all tumor sectors, and multiple amplifications and
deletions present at similar copy number in every sector. Similarly,
T2 contained 44 amplification and deletion breakpoints that were
common in position andmagnitude in all four tumor sectors. This
analysis indicates that these tumors contain highly similar profiles
in every sector, suggesting that T1 and T2 are each composed of
a single major monogenomic tumor subpopulation or a homoge-
neous mixture of subpopulations that are not resolvable by dis-
section alone.
In contrast, when we analyzed tumors T3 and T4, we noticed
a large degree of variation in the genome patterns of distinct sec-
tors. T3 contains 21 chromosomal breakpoints common to all four
sectors, but S3 of T3 also contains 16 new divergent chromosome
breakpoints not present in the other tumor sectors. These chro-
mosome breakpoints encompass three genomic amplifications
(6p22.1, 6p21.1, 17q21.32) and a deletion (21q11), none of which
are detectable in S1, S2, or S4. Thus at least two subpopulations are
evident in this polygenomic tumor. T4 displays yet another pat-
tern. Two sectors (S1 and S2) that contain high proportions of
tumor cells as assessed by histopathology (71% and 69%, respec-
tively) do not display prominent genomic rearrangements. Copy
number variation is observed even in normal genomes (Sebat et al.
2004). Sampling from this part of the tumor (S1 and S2), and using
previous genomicmeasures (Hicks et al. 2006), we would not judge
the tumor to be highly malignant. However, had we sampled from
sectors 3 and 4 (which display many prominent rearrangements,
including 98 breakpoints not present in sectors S1 and S2), we
would judge the tumor to be highly malignant.
Copy number analysis of tumors by sector and ploidy
To gain a clearer picture of the number of subpopulations and their
clonal relationship, we added a further tool for separating sub-
populations, fluorescence-activated cell sorting (FACS). Previous
studies have shown that FACS can be used to separate tumor cells
by ploidy for genomic analysis (Corver et al. 2008). FACS separates
subpopulations of tumor cells, and tumor cells from normal cells,
by differences in their total genomic DNA content, or ploidy. We
combined sectoring and FACS to isolated tumor subpopulations,
prepared DNA from all separable fractions, and applied ROMA to
16 tumors (Supplemental Table S1). We illustrate the SPP method
with a single example, tumor T10 (Fig. 1A–F).
T10 was cut in half along one axis, and six cuts were made
along an orthogonal axis, resulting in 12 pieces (Fig. 1A). Nuclei
were prepared from six of these pieces and then separated by FACS
into subpopulations distinguishable by total DNA content (Fig. 1B;
Supplemental Fig. S2). DNA from each peak was prepared and an-
alyzed using ROMA, and then the raw ratio profiles were segmented
using a circular binary segmentation (CBS) algorithm (Venkatraman
and Olshen 2007). The segmented profiles were always clearly re-
lated but sometimes distinguishable by their chromosome break-
point pattern (Fig. 1C). We also used Pearson correlations and
neighbor-joining algorithms to form distance trees that clustered
the profiles into similar and distinguishable subgroups (Fig. 1D). In
each case where we claim that a genomic breakpoint distinguished
two subgroups, we examined the raw data to rule out the possibility
of segmentation artifacts, namely, that the differences were not
merely of degree. To facilitate further comparisons between sub-
groups, we coalesced profiles within subgroups by calculating the
means of the segmented values from subgroups of individual CGH
profiles (Fig. 1E). To reveal the topography of the subpopulations,
we colored the sectors of the tumor in Figure 1F.
Classification of tumors
We classified 16 tumors into monogenomic and polygenomic by
SPP (Fig. 2). Seven tumors were considered monogenomic. Six of
the monogenomic tumors (T6, T7, T9, T11, T15, and T20) con-
tained in all sectors a single distribution of aneuploid nuclei with
DNA indices of 1.2 to 3.0 along with the expected diploid fraction
of index 1.0, presumably composed of stroma and immune cells.
The aneuploid fractions all showed abnormal CGH profiles, but
within each tumor this profile was highly similar in every sector.
One tumor (T16) had a single FACS peak (with a DNA index of 1.0),
but this peak contained a highly rearranged pseudo-diploid tumor
population in every sector, as revealed by CGH.
Nine tumors were classified as polygenomic and displayed
considerable complexity. Eight had multiple peaks of ploidy. In
every case, subpopulations distinguishable by total DNA content
were also clearly distinguishable by variation in their CGH profiles.
Three tumors had more than one aneuploid subpopulation distin-
guishable by FACS (T5, T10, T12). Three tumors had subpopulations
of pseudo-diploid cells exhibiting aberrant CGH profiles (T14, T17,
and T19). Five tumors had subpopulationswith genomic transitions
that were not evident from ploidy, but were distinguishable by
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sector when analyzed by CGH (T8, T13, T17, T18, T19). Two tumors
had hypodiploid subpopulations (T10 and T12).
Lineage of subpopulations
Similarities and differences between the profiles of subpopulations
within a tumor were often obvious by plotting segmented profiles,
but to discern variation with more rigor, we used computational
methods that scale with large numbers of profiles. In order to
equalize the dynamic range of amplifications and deletions, we
used the log of the intensity ratios in the segmented profile. We
computed the matrix of Pearson correlations between each in-
dividual profile and used a neighbor-joining algorithm (Saitou and
Nei 1987) computed from one minus the correlation to construct
distance trees between the profiles. We omitted the sex chromo-
somes to diminish extraneous correlation, and computed the dis-
tance using the segmented profiles to avoid the noise inherent in
raw copy number data. The trees were rooted using flow-sorted
diploid copy number profiles. The resultant trees for each profile
are shown in Figure 3. The trees divide into two groups: those with
Figure 1. Sector-Ploidy-Profiling (SPP) approach. The SPP approach separates tumor subpopulations by macro-dissection and cell sorting by ploidy. (A)
Macro-dissection of tumor sectors. (B) Sorting of DAPI-stained nuclei using FACS by differences in total genomic DNA content. (C ) Profiling of chro-
mosome breakpoints across the genome by ROMA CGH. (D) Calculation of neighbor-joining trees using copy number profiles. (E ) Coalescence of highly
similar copy number profiles. (F ) Topography of subpopulations in the tumor. Tumor sectors S7–S12 are colored according to the adjacent subpopulations
in S1–S6.
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a high correlation, >0.9 between all subpopulations (Fig. 3A),
and others that were less correlated (Fig. 3B). The former group
corresponds to the monogenomic tumor class and the latter to
polygenomic tumors, with one exception
(T8). In this case, the number of events
that distinguishes subpopulations is very
small: three focal amplifications on chro-
mosome 12q21.1 (Fig. 4A). These differ-
ences are readily apparent by examining
graphs of the segmented profiles, but less
so by the mathematical measures. The
color coding of the leaves of the tree
match the color coding of Figure 2 and
represent profile subgroups.
Overall, subpopulations within a tu-
mor are very similar and share many or
most chromosome breakpoints. On the
other hand, we see very few common
breakpoints between different tumors.
This strongly implies that all subpop-
ulations within a tumor have a common
clonal origin. Given the potential im-
portance of this conclusion, we felt it
useful to validate it by purely computa-
tional analysis. The result of distance
clustering of all tumor subpopulations
clearly confirms that the subpopulations
within a tumor are vastly more related to
each other than the subpopulations be-
tween tumors (Fig. 3C). We cannot rule
out that some tumors are mixtures of to-
tally distinct clones, but we have never
seen evidence for this alternate hypothe-
sis (e.g., by observing two completely
unrelated subpopulations within the
same tumor).
Tumor progression
The order of progression can be inferred
from subpopulation data if we make two
assumptions. The first assumption is that
the tumor subpopulations have arisen
from a common progenitor tumor cell.
The second assumption is that there is no
‘‘reversion to normal’’ in a lineage once
a change occurs. In other words, observ-
able mutations only accumulate. There
can be violations of this assumption, for
example, if a chromosome with changes
is subsequently lost. Also, violations of
this assumption can arise due to observ-
ing mixtures of subpopulations.
In almost all cases, the subpopula-
tions within a tumor have many similar
copy number changes (Fig. 4), but have
few in common with other tumors, justi-
fying the assumption of a commonorigin
for subpopulations in each individual tu-
mor. However, tumor T4 had sectors with
essentially no discernible copy number
changes (‘‘flat’’ profiles), and other sec-
tors with many chromosomal breakpoints (Supplemental Fig. S1).
The sectors with flat profiles nevertheless were full of malig-
nant cells as judged by histopathology. Thus a common origin for
Figure 2. Summary of Sector-Ploidy-Profiling (SPP) results for tumors T5–T20. (A) Monogenomic
tumors. (B) Polygenomic tumors. Tumors were cut into four to six sectors. Nuclei were isolated from
each sector and sorted by FACS according to differences in total genomic DNA content. DNA content is
plotted on the x-axis (calibrated with a normal diploid control with a DNA index 1.0). Tumor sectors are
plotted on the y-axis (S1–S6). Filled blocks indicate FACS peaks. Colors represent different sub-
populations as distinguished by their CGH profiles: (blue) hypodiploid; (green) normal diploid; (orange,
red, purple) distinguishable aneuploid tumor subpopulations. The total number of colors used in the
schematic of a given tumor is the same as the total number of subpopulations distinguished in that
tumor. For example, tumor T12 contains four subpopulations: one diploid subpopulations present in all
sectors, one hypodiploid subpopulation present only in sectors 1–3, one aneuploid subpopulation
present only in sectors 4–6, and a second aneuploid subpopulation present only in sectors 5–6.
Inferring tumor progression from heterogeneity
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tumor cells with flat profiles and for those with copy number
changes cannot strictly be inferred.
In the general case, we assume a common clonal origin and
make inferences about the order of progression. Two of the most
extreme examples of progression are seen in tumors T10 and T12,
whichhave a hypodiploid state and an aneuploid state (Figs. 2B, 5).
Using the assumption of irreversibility, we can assert that the an-
euploid state derives from the hypodiploid state, as the aneuploid
tumor cells display many more chromosomal breaks (Fig. 5). The
T10 and T12 hypodiploid cancer genomes have what we pre-
viously called a ‘‘saw-toothed’’ profile (Hicks et al. 2006). This
pattern is associated with basal-like expression breast cancer
Figure 3. Distance trees of copy number profiles. Neighbor-joining trees were constructed from distance trees by calculating 1-correlation matrices of
all copy number profiles in a single tumor. (Green) The trees were rooted with a single coalesced diploid profile. (Green) Monogenomic tumors; (red)
polygenomic tumors. (Red, yellow, blue) The leaves are colored to show different subpopulations as determined by comparing ROMA copy number
profiles. (A) Tumor trees with a minimum correlation coefficient > 0.9. (B) Tumor trees with a minimum correlation coefficient < 0.9. (C ) Distance trees of
all tumor profiles without a diploid root node. Two trees were calculated separately: one from 85K experiments (T4–T14) and one from the 390K
experiments (T15–T20).
Navin et al.
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subtypes (Bergamaschi et al. 2006; Chin et al. 2006). In these two
examples, the hypodiploid subpopulation progress to aneuploid
and acquire focal amplifications and deletions.
The most prominent differences between populations were
changes in the copy number of broad chromosomal regions.
However, many polygenomic tumor subpopulations diverged by
a small number of focal (narrow) genetic events, and we may infer
that these focal changes occurred ‘‘late,’’ after tumor initiation and
considerable expansion.Overall, we identified 24 focal lesions that
differed between tumor subpopulations: 12 amplifications and 12
deletions (Supplemental Table S2). As we expected, many focal
amplifications encompassed known oncogenes, including KRAS,
PPP1R12A, HRASLS, MYC, RAD52, and RARA; while the deletions
eliminated known tumor suppressors: CDKN2A, CASK, EFNA5,
Figure 4. Focal lesions that differ between subpopulations in single tumors. Segmented log ratio CGH data from coalesced tumor profiles are plotted in
genome order. (A) Tumor T8 contains three focal amplifications, including the amplification of the PPP1R12A locus on Chr12q21, which is present in the
A2 tumor subpopulation (red), but absent in A1 (yellow). (B) Tumor T10 contains a focal amplification of the KRAS locus on Chr12p12.1, which is present in
the A2 tumor subpopulation (red), but absent in A1 (yellow). T8 also contains a homozygous deletion of the EFNA5 and FER locus on Chr5q21.3 in the (red)
A2 subpopulations that is hemizygously deleted in A1 (yellow). (C ) Tumor T19 contains a focal amplification of the PTPN2 locus on Chr18p11.21, which is
present in the A2 subpopulation (red), but absent in A1 (yellow). T19 also contains a focal amplification of the MCM10 locus on Chr10p13 in the A1 tumor
subpopulation that is absent in A2.
Inferring tumor progression from heterogeneity
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FER, PAX8, and ERCC3 (Futreal et al. 2004). Furthermore, we iden-
tified many focal deletions and amplifications containing single
genes not previously implicated in cancer, including CACNA1C,
HYDIN, SLC6A15, DCLK2, DNER, and C11ORF87.
We illustrate focal differences with
three polygenomic tumors (T8, T10, and
T19). The T8 tumor subpopulations di-
verged by only three tandem genomic
amplifications on chromosome 12q21.1
present in the A1 tumor subpopulations
in sectors 4 and 5, but not sectors 1 to 3
(Fig. 4A). These focal regional amplifica-
tions encompassed three single genes—
BC061638, SLC6A15, and PPP1R12A—
the former of which have not previously
been implicated in cancer. The T10 tumor
subpopulations diverged by only a single
genomic amplification and a single de-
letion (Fig. 4B). The region of chromo-
some 12p12.1 contains the KRAS onco-
gene and was present at greater than 10
copies in the A2 subpopulation in sectors
5 and 6, but was only present in three
copies in the A1 subpopulation. The T19
tumor subpopulations diverged by two
amplifications on chromosome 10p14-
p12.33 and 18p11.21 containing the
MCM10 and PTPN2 oncogenes, respec-
tively. In the next section, we use these
focal changes to analyze the spatial re-
lationship of subpopulations by FISH.
Spatial organization of subpopulations
It is evident even from our crude dissec-
tions that some tumor subpopulations
are regionally segregated, while in other
cases, two or more subpopulations co-
occupy the same sector. To explore this
further, we used interphase FISH to visu-
alize single tumor cells using the sub-
population-specific chromosomemarkers
in tumor T10 (Fig. 7B, see below). Tumor
T10 is made up of one hypodiploid sub-
population (H) occupying sectors 1–3
and two distinct aneuploid tumor sub-
populations (A1 and A2) that co-occupy
sectors 5 and 6 (Fig. 1). The A2 tumor
subpopulation diverges from the A1 sub-
population by only two genetic lesions:
a homozygous deletion on chromosome
5q21.1-22.1 and the amplification of
more than 10 copies of the KRAS locus at
12p12.1 (Fig. 4C). Both of the other tu-
mor subpopulations (A1 and H) carry
three copies of KRAS according to their
CGH profiles. Thus, a FISH probe to the
amplified KRAS locus serves to distin-
guish A2 from both A1 and H sub-
populations.
The regional segregation of tumor
subpopulations predicted by ROMA is
confirmed in T10 through interphase FISH by hybridizing a KRAS
probe to the six tissue sections corresponding to the sectors ana-
lyzed by ROMA (Fig. 6). Many of the tumor cells from sectors 5
and 6 contained a highly amplified KRAS locus. Within the other
Figure 5. Genomic progression from hypodiploid to hyperaneuploid. Coalesced, segmented copy
number profiles are ordered in increasing numbers of chromosome breakpoints. The topography of the
subpopulations in the tumor sectors is shown with a white vector to indicate the direction of pro-
gression. FACS histograms are shown with the gated subpopulation highlighted in color. (A) Tumor T10
progresses from diploid (D) (green) to hypodiploid (H) (blue), to hyperaneuploid (A1) (yellow), to
hyperaneuploid (A2) (red), as the number of chromosome breakpoints increases. (B) Tumor T12
progresses from diploid (D) (green) to hypodiploid (H) (blue) to hyperaneuploid (A1) (yellow). (C )
Illustration of the clonal expansion of subpopulations that occur as the tumor grows.
Navin et al.
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sectors (1–4), the stroma and tumor cells
exhibited just two or three copies of the
KRAS locus expected from the CGH pro-
files. However, in two microscopic fields
of about 500 tumor cells in sector 4, we
observe one isolated cell that was highly
amplified for KRAS (Fig. 6E).
The presence of multiple tumor sub-
populations in sectors is obvious in tu-
mors where the FACS histograms con-
tain multiple aneuploid peaks. It is not
clear from FACS, however, whether these
co-occupied sectors result from our gross
dissection crossing a boundary between
segregated neighborhoods, or, alterna-
tively, from an organization in which the
subpopulations physically intermix. To
further explore this level of organization
in tumor T10, we used a complex of
FISH probes capable of distinguishing
subpopulations A1 and A2 from normal
stroma and from each other. To distin-
guish A1 and A2 from normal stroma, we
used aMYC probe present in both the A1
and A2 at a copy number of three. To
distinguish A2 from A1, we used two
probes (ETNK and KRAS) that colocalize
to the region with a highly amplified
KRAS locus in A2. We visualized all cells,
tumor and diploid, using two probes,
LCON and RCON, that map just outside
the amplified region on A2. The probe
scheme and location of the mixed sector
5 of T10 are shown in Figure 7B. The re-
sults of multicolor FISH performed on
tissue sections from sector 5 are shown
in Figure 7, C and D. These FISH experi-
ments allowed us to clearly identify the
diploid cells, the A1 subpopulation and
the A2 subpopulation (D, A1, and A2 in
Fig. 7C,D) and reveal that single A1 andA2
tumor cells are intermixed, rather than
occupying separate domains (Fig. 7E,F).
Discussion
Dissecting the clonal composition of tu-
mors at the genetic level is key to un-
derstanding the nature and progression
of cancer and assessing prognosis and
treatment. Genomic heterogeneity has
long been reported in breast tumors, but
with conflicting results, some suggest-
ing that breast tumors are homogeneous
(Noguchi et al. 1992, 1994; Endoh et al.
2001) and some heterogeneous (Teixeira
et al. 1995, 1996; Farabegoli et al. 2001;
Shipitsin et al. 2007). These reports were
based on analysis of single samples from
whole tumors, in which the subpop-
ulationswere not separated by differences
in topography or ploidy. Only one study
Figure 6. Regional amplification of the KRAS locus. Tissue sections from sectors 1–6 from tumor T10
are hybridized with a single FISH probe specific to the KRAS locus. (B–G, left) The topography of each
tumor sector from which the tissues sections are cut. The log ratio and segmented copy number data of
the KRAS amplification are also shown for each tumor sector. (A) Ideogram showing the cytobands and
location of the KRAS FISH probe on chromosome 12p12.1. (B–D) Tissue sections from sectors 1–3 show
two or three copies of the KRAS locus in the stromal and tumor cells. (E) Sector 4 contains a majority of
tumor and stromal cells with two or three copies of the KRAS locus; however, one tumor cell shows
a massive amplification of the KRAS locus. (F–G) Sectors 5 and 6 show numerous tumor cells with a high
copy number of KRAS as a homologous staining region intermixed with other stromal and tumor cells
that contain two or three copies of the KRAS locus.
Inferring tumor progression from heterogeneity
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examined genomic variation in regionally separated tumor quad-
rants using CGH and concluded that some breast tumors had ge-
netically distinct quadrants (Torres et al. 2007). Our preliminary
analysis of T1–T4 in which we used sectoring and CGH is consis-
tent with this earlier study. In our full study, we analyze a larger
number of samples, and more sectors per tumor, and use separa-
tion of subpopulations by ploidy as well as FISH to study the clonal
composition of tumors. As a result, we describe heterogeneity in
both greater breadth and detail, enabling us to infer the pro-
gression of subpopulations.
In summary, we find that clonal genomic heterogeneity in
breast cancers is very common. We identified 11 polygenomic
tumors in our sample of 20. In heterogeneous tumors, we observed
that the subpopulations may be anatomically separate or inter-
mixed. We also find that these tumors consist of only a few major
subpopulations. As we showed for one case, differences in the ge-
nome of subpopulations can be exploited to visualize the pop-
ulation substructure of a solid tumor by FISH, enabling us to un-
ravel the developmental organization of tumor growth and the
migratory pattern of cells within the tumor. From the shared
chromosomal breakpoints, we infer that tumor subpopulations
have a commongenetic lineage. By comparing subpopulations, we
can infer the order of certain genomic events.
In some tumors (T4, T5, T10, T12, and T14) the sub-
populations differ by many genomic events. In the case of T4, we
observe one subpopulation without discernible genomic copy
number changes and another subpopulation withmany events. In
a previous study (Hicks et al. 2006), we reported that ;10% of
breast cancers had profiles with no discernible events. Perhaps
those profiles arose from analysis of breast cancers in very early
stages or from sampling only one subpopulation in the tumor. In
all the other cases reported here, the subpopulations share many
chromosomal events, but the total number of events is sub-
stantially greater in certain subpopulations. In T10 and T12 the
Figure 7. Intermixing of tumor subpopulations in tissue sections. A FISH probe strategy was used to mark chromosomes that are differentially amplified
in two tumor subpopulations (A1 and A2) in tissue sections from sector 5 and sector 6 of T10. (A) Tumor T10 contains four sectors (S11, S12, S5, S6) with
similar FACS histograms. The FACS histogram from sector 5 is shown and contains one diploid peak (green) and two aneuploid peaks that were gated and
analyzed by CGH (yellow and red). (B) Segmented copy number data are plotted with FISH probes annotated to show the strategy for distinguishing the
diploid cells from the A1 and A2 tumor subpopulations. TheMYC probe on chromosome 8q24.21 (orange) detects two copies in the diploid cells and three
copies in both of the tumor subpopulations (A2 and A3). LCON (purple) and RCON (blue) are control FISH probes on Chr12p12.1 that report two copies in
all of the subpopulations. The KRAS (red) and ETNK (green) probes report six to 10 copies in the A2 subpopulation, but not in A1. (C,D) Tissue sections from
T10 sector 5 show three types of cells: D diploid, A1 tumor cells, and A2 tumor cells. Diploid cells contain two copies of all of the probes. A1 tumor cells
contain three copies of MYC and two copies of the other probes. The A2 tumor cells display a bright yellow signal resulting from the colocalization of the
KRAS and ETNK probes, which are present in high copy number. (E,F ) DAPI channels are false-colored to show the location of the three cell types: D (green),
A1 (yellow), and A2 (red) in the tissue sections from panels C and D. The three cell types are stochastically intermixed in the tissues.
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subpopulations with lower numbers of events are hypodiploid,
and the subpopulations with higher numbers are clearly aneu-
ploid, strongly suggesting that a hypodiploid state preceded the
aneuploid state. These two were the only tumors displaying the
‘‘sawtooth’’ pattern of genomic breaks (Hicks et al. 2006). Recent
experiments have shown evidence that the basal-like expression
subtype of breast cancer and BRCA1 tumors display the saw-
toothed genome profile, with extensive low-level chromosomal
loss and gains (Bergamaschi et al. 2006; Chin et al. 2006). Our re-
sults suggest that the extensive chromosomal loss may represent
a common early stage in the evolution of basal-like subtypes,
which is then followed by increased ploidy.
In contrast, in some tumors the subpopulations differ by only
a few focal events. Events common to two profiles are ‘‘early’’ (prior
to their divergence), while events unique to the profiles are ‘‘late’’
(after their divergence). In Supplemental Table 2 we list those focal
changes that we classify as ‘‘late’’ and are therefore implicated in
progression as opposed to initiation. These loci containmanywell-
known cancer genes, such as KRAS, which were first discovered on
the basis of being able to initiate malignancy; however, many loci
contain single genes that have not previously been implicated in
cancer (Supplemental Table S2) and are worthy of more study.
Many of the focal amplifications and deletions that we identified
are regionally segregated in the tumor (Supplemental Table S2).
Regional amplifications have previously been reported in glio-
blastomas, where the amplification of EGFR was shown to occur
only in specific anatomical locations (Nafe et al. 2004). Our data
show that regional amplifications and deletions occur frequently
in the polygenomic breast tumors.
Several, but not all, polygenomic tumors showed evidence of
two tumor subpopulations co-occupying a tumor sector. SPP is
insufficient to determine if the co-occupying subpopulations are
intermixed at the cellular level. However, once subpopulations are
identified, molecular markers can be used to examine the spatial
organization of the subpopulations at the cellular level. For ex-
ample, tumor T10 had three tumor subpopulations: H, A1, and A2,
with the latter two intermixed. A1 and A2 were very similar, dif-
fering by a massive amplification of the KRAS locus. This amplifi-
cation, and the amplification of nearby genes, provided us with
FISHmarkers to distinguish A2 fromA1 in tissue sections. Based on
the discrete breakpoints of the amplicon in ROMA profiles of both
S5 and S6, we believe that this amplification occurred in a single
cell similar to the A1 subpopulation that subsequently underwent
clonal expansion and finally diverged to become the A2 sub-
population present throughout these sectors. We observed a pat-
tern of extensive intermixing of A2 and A1 in sectors 5 and 6, and
very limited penetration of A2 in sector 4. We can think of three
reasonable and nonexclusive explanations for intermixing sub-
populations. First, the subpopulations A1 and A2 cooperate, and
their mutual presence has a selective advantage. Second, A1 pro-
vides a hospitable environment intowhichA2 can invade,whereas
normal stromamixedwithHdoes not. Last, A2 originated in sector
6 and has only begun invading its way back into the remainder of
the tumor. The last explanation is consistent with recent experi-
ments suggesting that the overexpression of KRAS leads to in-
creased cell migration (Fotiadou et al. 2007).
In our study, we analyzed only histological grade III (18/20)
and grade II (2/20) ductal carcinomas (see Supplemental Table S1).
Thus we could not correlate different tumor grades with the
monogenomic or polygenomic classes. However, the fact that we
observe both classes in grade III tumors suggests that they do not
represent exclusive stages of progression. We also tested for corre-
lation of clinical parameters including ER, PR, and Her2 status
(when available) for each tumor with the monogenomic and poly-
genomic classes using the Fischer’s exact test, but did not find any
significant correlations (data not shown). Some triple negative
tumors, for example, were classified as monogenomic and some as
polygenomic tumors. While our samples were limited to only 20
tumors, our current data suggest that the ER, PR, and Her2 clinical
parameters show no specific correlation with either class of geno-
mic heterogeneity. Furthermore, we scored the tumor grade in
H&E-stained tissue sections from the four to six sectors of T1–T10
to see if a change in tumor grade correlated with the polygenomic
tumors. We found no significant correlations: Polygenomic tu-
mors often contained the same high grade (III) in all four to six
tumor sectors. We do not have expression data for the tumors we
studied, so we cannot say if the expression subtype correlates with
genomic heterogeneity, or if heterogeneity accounts for the failure
of some breast cancer expression profiles to classify neatly into
subtypes.
Much can be learned by discerning the subpopulations in
a tumor and their spatial organization. Such analysis can be used to
explore theories of cancer progression, patterns of growth (Norton
and Massague 2006), migration, and metastasis (Liu et al. 2009)
and may be of use in clinical settings. For example, clinical pa-
thologists have long been aware of tumor heterogeneity and report
the highest tumor grade observed after a fairly exhaustive survey of
the tumor mass. However, as we have shown here, histological
heterogeneity does not by itself imply genomic heterogeneity or
vice versa. Genome-wide measures derived by sampling a single
region may not be representative of the entire tumor when sub-
populations are anatomically segregated. The degree of genomic
heterogeneity itself might be a useful clinical parameter and could
be missed entirely if not deliberately sought.
The clonal evolution models for tumor progression are con-
sistent with our results in the polygenomic tumor subpopulations.
The primary assumption of the clonal evolution models (mono-
clonal and polyclonal) is that the majority of cancer cells are ca-
pable of unlimited proliferation. This assumption contrasts with
the fundamental assumption of the cancer stem cell hypothesis,
which states that only a rare subpopulation of tumor cells is ca-
pable of unlimited proliferation, while the vast majority are only
capable of normal cell division potential. In the polygenomic tu-
mors, we observed that the majority of chromosome breakpoints
are persistent throughout the tumor in all subpopulations, sug-
gesting that the majority of cells are capable of unlimited pro-
liferation.
Clearly, cancers must evolve by a series of discrete events, so
finding heterogeneity is not unexpected. What is perhaps sur-
prising is that our data show that the genomic heterogeneity of
tumors can be ascribed to relatively few homogeneous sub-
populations. While we do see evidence of gradualism in some
subpopulations, there are often large gaps in some of the distance
trees constructed from profiles of subpopulations from the poly-
genomic tumors. Similar observations of gaps in the fossil records
plague models of biological evolution (Eldredge and Gould 1972).
Moreover, in all cases, the ‘‘inferred’’ common progenitor of sub-
populations is already at a great distance from ‘‘normal’’ (Fig. 3).
Apparent gaps in the distance tree can be explained several ways.
Perhaps only after the slow accumulation ofmultiple changes does
a cancer subpopulation suddenly emerge with an enhanced ca-
pacity for clonal expansion. Alternatively, sudden changes in ge-
nomic profile occur by catastrophic mitotic events or by cell fu-
sion, with the subsequent destabilization of the chromosomes. In
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some cases, something even more radical might be occurring: The
cancer gradually evolves off-site at a distant metastasis, acquiring
a dramatically altered profile, and then returns to the primary and
greatly expands its mass.
We observe a significant proportion of tumors that are ap-
parently monogenomic, and even in the polygenomic tumors we
never distinguish more than three major tumor subpopulations.
However, our assessment of tumor heterogeneity is likely to be an
underestimate.Minor and very heterogeneous subpopulationswill
be averaged into main subpopulations if they share DNA index.
Moreover, the tumor dissection will not in general follow the
natural boundaries of subpopulations, further blurring our as-
sessments. We are limited in our method of separating sub-
populations by sector and ploidy. However, we are currently ex-
ploring a method that does not share these limitations, namely,
the analysis of copy number in tumors by single-cell DNA se-
quencing. Although not without its own limitations, single-cell
analysis has the potential to further clarify the extent and origins
of tumor heterogeneity, and more importantly, the genetic path-
ways of tumor progression.
Methods
Patient samples
Twenty frozen primary ductal carcinomas were obtained from the
Cooperative Human Tissue Network (T1–T7), Peggy Kemeny at
North Shore University Hospital (T7–T8), Asterand Corporation
(T16–T17), Larry Norton at Memorial Sloan-Kettering Cancer
Center (T12–T14), and from Hanina Hibshoosh at Columbia
University (T19–T20).
Sector macro-dissection
The 1–2-cm2 frozen tumors were macro-dissected into eight to 16
sectors of equal size using surgical scalpels. Half of the sectors from
each tumor were used to prepare tissue sections at 6 mm in size
using a cryomicrotome. The other half of the adjacent tumor sec-
tors were used to isolate nuclei for SPP.
FACS
Nuclei were isolated from tumor samples by finely mincing a tu-
mor sector in a Petri dish in 1.0–2.0mLofNST-DAPI buffer (800mL
of NST [146 mM NaCl, 10 mM Tris base at pH 7.8, 1 mM CaCl2,
21 mM MgCl2, 0.05% BSA, 0.2% Nonidet P-40]), 200 mL of
106 mM MgCl2, 10 mg of DAPI, and 0.1% DNase-free RNase A
using two no. 11 scalpels in a cross-hatching motion. Minced tis-
sue was stored on wet ice for 15 min. Before flow cytometric
analysis, samples were filtered through 37-mm plastic mesh. In all
LSRII and FACS Vantage analysis, a small amount of prepared
nuclei from each tumor sample was mixed with a diploid control
sample (derived from a lymphoblastoid cell line of an apparently
normal person) to accurately determine the diploid peak position
within the tumor DNA content distribution and establish FACS
collection gates. Nuclei were sorted with a Becton Dickinson FACS
Vantage DiVa Flow Cytometer and Cell Sorter by gating cellular
distributions with differences in their total genomic DNA content
according to DAPI intensity. Additionally, a small sample of cells
(n < 5000) from the adjacent sectors (that were used for histology)
had nuclei isolated and stained with DAPI for analysis by a Becton
Dickinson LSRII flow cytometer to generate a histogram of the
DNA distributions in order to determine if they were consistent
with the flow-sorted tumor sectors.
Comparative genomic hybridization using ROMA
DNA was isolated from the flow-sorted nuclei using the QIAGEN
Genomic DNA Isolation Kit. A total of 200 ng of DNA was used to
make complexity-reducing representations of genomic DNA for
whole-genome copy number analysis by ROMA as described by
Grubor et al. (2009). ROMA greatly increases signal-to-noise ratios
and diminishes the amount of sample required for analysis;
therefore, no additional whole-genome amplification step was
required from the tumor sectors. Samples were hybridized on two
array platforms: 85K arrays based on BglII representations (samples
T1–T14), and 390K arrays based on DpnII representations, de-
pleted of DpnII fragments containing AluI sites (T15–T20). The
microarrays were custom designed with probes complementary to
the complexity-reducing representations and manufactured by
NimbleGen. Hybridizations of the 85K experiments were per-
formed in color reversal to prevent color bias and ensure data
quality, while 390K experiments were performed without a dye
swap. All tumor samples were cohybridized with a reference ge-
nome from fibroblast DNA.
Informatics
The ROMA experiments were scanned, gridded, and normalized
with a Lowess curve-fitting algorithm followed by a local nor-
malization as described by Hicks et al. (2006). The data were im-
ported and analyzed using Splus (Insightful) and Matlab (Math-
works), and the geometric mean ratio was computed from each
color channel. In color-reversal experiments, the geometric mean
of two log ratios was calculated. The data were then segmented to
define nonoverlapping genomic regions that vary in copy number
across the human genome using both the Kolmogorov-Smirnov
algorithm (Grubor et al. 2009) and the circular binary segmenter
(Venkatraman and Olshen 2007). The segmented genomic copy
number profiles from each sector were then used for the statistical
analysis.
Fluorescence in situ hybridization
FISH probes were constructed by one of two methods. The KRAS
probe used in Figure 6 was designed using the PROBER algorithm
and pooled from PCR products 500–1400 bp in length (Navin et al.
2006). The LCTR, RCTR, ETNK, and KRAS probes were designed
using bacterial artificial chromosomes from the UCSC Genome
Browser. FISH analysis was conducted on interphase cells in 10-mm
frozen tissue sections. These probes were hybridized to frozen tis-
sue sections that were fixed in methanol overnight and moved to
70% ethanol. The FISH experiments were performed as reported by
Hicks et al. (2006) with DAPI staining to visualize the nucleus.
Selected cells were photographed in a Zeiss Axioplan 2microscope
equipped with an Axio Cam MRM CCD camera and Axio Vision
software.
In order to mitigate the analysis of shaved nuclei, we
employed three precautionary steps. First, we cut relatively large
(7 mm) tissue sections using a cryomicrotome in order to encom-
pass whole nuclei. Second, we captured Z-planes that contained
40–50 images from each 633 objective microscope using a me-
chanical stage. Using Axiovision Software, we generated Z-plane
images of the DAPI-stained nuclei, which we used to exclude any
partially shaved nuclei in the quantification of FISH probe signals.
Third, we hybridized two diploid control probes to all nuclei
(RCON and LCON) that surround the KRAS amplification on
chromosome 12p12.1 and aMYC control probe on chromosome 8.
These control probes served as indicators that the nucleus was not
shaved on chromosome 12p12.1. When we did not observe two
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copies of each control probe in the nucleus, it was not scored for
copy number. Using these three criteria, we observed that the
majority of cells that we scored (89.69%) showed copy number
signals consistent with one of three subpopulations: D, A1, or A2.
However, some nuclei (10.31%) did report patterns of copy num-
ber that were inconsistent with the predicted subpopulations.
We cannot distinguish if these nuclei represented a minor sub-
population or if they were shaved nuclei. Finally, in order to avoid
probe artifacts, we did not score any nuclei where the probes did
not overlap the DAPI channel.
Statistics
In order to identify highly similar copy number profiles in single
tumors for profile coalescing, we calculated a matrix of Pearson
correlations between profiles and used a neighbor-joining algo-
rithm (Saitou and Nei 1987). The neighbor-joining algorithm was
used in place of an ultrametric method because we did not assume
an equal distance from each copy number profile to the root node.
In our calculations of correlationmatrices, we used segmented data
from the autosomes in order to exclude extraneous correlations
from the sex chromosomes, and since our reference sample was
male. The correlation matrix was converted to a distance matrix
using (1-correlation). Clusters of highly similar copy number pro-
files were then ‘‘coalesced’’ into mean segmented profiles to repre-
sent each subpopulation in a single tumor. The pairwise differ-
ence between coalesced profiles was then calculated to identify
subpopulation-specific amplifications and deletions. Each geno-
mic lesion was annotated to identify UCSC genes (Hsu et al. 2006)
and cancer genes. Cancer genes were identified using a compiled
database from the cancer gene consensus (Futreal et al. 2004)
and the NCI cancer gene index (Sophic Systems Alliance Inc., Bio-
max Informatics A.G). Distance trees were calculated using the
same methods for coalescing profiles (1-Pearson correlations and
neighbor-joining). A single distance tree was calculated for each
tumor (Fig. 3A,B). Additionally, the minimum correlation between
all tumorprofiles is reported as the clonal correlation (cc), ameasure
of intratumorheterogeneity in Supplemental Table S1. In a separate
analysis, we used the same methods to construct a distance tree
using all tumor copy number profiles. In this analysis, we clustered
the 85K (T4–T14) and 390K (T15–T20) tumor profiles separately
and did not use any diploid profiles as a root node (Fig. 3C).
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